The record
Written from the 3 reports below. Nothing here is unsourced.
- The Union health ministry has issued an advisory restricting stem cell therapy for autism to approved clinical trials only.
- The advisory, issued on September 16, bars unproven stem cell interventions from being offered as routine, standard or commercial clinical services.
- The action follows a Supreme Court judgment on the regulation of stem cell therapy in India.
- Stem cell trials for autism must comply with the National Guidelines for Stem Cell Research, 2017, issued by ICMR and the Department of Biotechnology.
- The ministry has warned that offering such therapy outside the approved framework can attract consequences including professional misconduct, so families seeking autism treatment should know clinics cannot sell unproven stem cell therapy as standard care.
What to watch next
- How states and Union Territories circulate the Supreme Court's directions to district regulators and clinics
- Whether action is taken against establishments offering unapproved stem cell therapy
- Approval of new clinical trials for autism stem cell therapy under the 2017 national guidelines
What changed3
Every report on this story, newest first. Times are when each outlet published.
Hindustan Times[1]
Stem cell therapy only for approved conditions: GovtMint[2]
Health ministry bars stem cell therapy for autism as routine careThe Hindu BusinessLine[3]
Health ministry tightens rules on stem cell therapy, bars routine use for autism
Who said what2
Only words found exactly in the article are shown, attributed and linked to the line they came from.
Rajeev Jayadevan
public health expert
2 quotes · 1 outlet
“Stem cells represent a complex and continuously evolving field in healthcare. The premise that these cells can differentiate into other cell types may lead some people to believe they can cure several common conditions”
In the article
…disciplinary action in accordance with the applicable statutory and regulatory provisions”. On 19 August, Mint reported that India has issued strict norms for stem cell therapies. 'A continuously evolving field' " Stem cells represent a complex and continuously evolving field in healthcare. The premise that these cells can differentiate into other cell types may lead some people to believe they can cure several common conditions ," said Dr Rajeev Jayadevan, a public health expert and former IMA president at Kochi Chapter. “However, the reality is far more nuanced. Using them as unproven treatments carries not only the risk of failure, but also…
“Using them as unproven treatments carries not only the risk of failure, but also unexpected adverse health outcomes.”
In the article
…types may lead some people to believe they can cure several common conditions," said Dr Rajeev Jayadevan, a public health expert and former IMA president at Kochi Chapter. “However, the reality is far more nuanced. Using them as unproven treatments carries not only the risk of failure, but also unexpected adverse health outcomes. Worldwide, strict regulations govern how and for what conditions stem cells can be used. As data from well-designed clinical trials emerge in the future, stem cell therapies are likely to gain regulatory approval for…
Why it matters4
Who is affected first and what likely follows, with a direction and a horizon. Extracted from the reports, never invented.
- Private clinics offering stem cell therapy for autism in India prohibited from offering unapproved treatment· immediate
- Families of children with autism in India restricted access to stem cell therapy· immediate
- Patients and families reduced risk of unproven treatment harm· days
- Stem cell research sector in India funneled into approved clinical trials· weeks
Coverage3
All filed from India
Named India · Department of Biotechnology · Indian Council of Medical Research · Ministry of Health and Family Welfare · National Medical Commission · Rajeev Jayadevan · Supreme Court of India · Yash Charitable Trust
- Hindustan TimesStem cell therapy only for approved conditions: Govt[1]English national· neutral
- MintHealth ministry bars stem cell therapy for autism as routine care[2]English national· neutral
- The Hindu BusinessLineHealth ministry tightens rules on stem cell therapy, bars routine use for autism[3]English national· neutral
The 3 reports are listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.